Genomic landscape of EGFR-TKI resistance: from known mechanisms to unknown resistance

Cellular Oncology · Published 2026-08-04 · DOI 10.1007/s13402-026-01253-y

Free full text

Authors (5)

Songchen Zhao, Fei Zhou, Wenshuai Chen, Shuchun Wang, Caicun Zhou

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zhao, S., Zhou, F., Chen, W., et al. (2026). Genomic landscape of EGFR-TKI resistance: from known mechanisms to unknown resistance. Cellular Oncology. https://doi.org/10.1007/s13402-026-01253-y

Related articles

• The ubiquitin-like protein FAT10 enhances the autophagy-mediated degradation of ZO-1 by stabilizing ATG3 to promote the lung metastasis of colon cancer · Cellular Oncology · 2026 · Same journal
• Reverse cardio-oncology: neuroendocrine axis activation and cardiovascular-disease-derived factors synergistically remodel the tumor microenvironment · Cellular Oncology · 2026 · Same journal
• TFAP2A enhances radioresistance of non-small cell lung cancer by transcriptionally activating BRCA1 · Cellular Oncology · 2026 · Same journal
• NAA50-mediated SLU7 stabilization promotes cisplatin resistance in bladder cancer via regulating MAP3K3 mRNA nuclear export and p38 MAPK activation · Cellular Oncology · 2026 · Same journal
• Lactylation shields S100A11 from degradation to promote gastric cancer metastasis · Cellular Oncology · 2026 · Same journal
• RNF114-PACSIN3 signaling axis promotes hepatocellular carcinoma progression by enhancing GLUT1 membrane retention and glucose uptake · Cellular Oncology · 2026 · Same journal
• Cis-3-hexen-1-ol suppresses bladder cancer progression by inducing mitophagy via the PCK2/AMPK/mTOR signaling pathway · Cellular Oncology · 2026 · Same journal
• Inhibition of DLX6 sensitizes lung adenocarcinoma to cisplatin via GPX4-dependent ferroptosis · Cellular Oncology · 2026 · Same journal
• Tumor lymph node metastasis chip reveals that the NECTIN3-TIGIT axis promotes melanoma metastasis by enhancing treg cell function and inducing CD8+ T cell exhaustion · Cellular Oncology · 2026 · Same journal
• Targeting PRMT5 to reshape the immune microenvironment and reverse Trop2 ADC resistance in triple-negative breast cancer · Cellular Oncology · 2026 · Same journal